Clinical Trial

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers

Name: Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers — clinical trial record (NCT07598968)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This clinical trial is a two-arm, open-label, single-sequence, multiple oral dosings, cross-over design clinical trial to evaluate the safety and pharmacokinetic characteristics of HL1113-R1 and HL1113-R2 in healthy adult volunteers

Trial Details

NCT Number	NCT07598968
Lead Sponsor	Hanlim Pharm. Co., Ltd.
Conditions	Hypertension, Diabete Type 2
Enrollment	35 participants
Start Date	2023-06-18
Primary Completion	2023-07-12 (estimated)
Study Completion	2023-07-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-20